Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
Kamada Ltd., a biopharmaceutical company listed on Nasdaq and TASE, disclosed that it has obtained a tax ruling from the Israel Tax Authority allowing Nasdaq shareholders residing in treaty countries to potentially benefit from reduced Israeli withholding tax rates on the cash dividend of $0.25 per share scheduled for April 7, 2026. The company app…